Global Rapid Tests Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Rapid Tests Market Research Report 2024
Rapid tests are often referred to as point-of-care tests because rather than sending a blood sample to a laboratory, the test can be conducted and the result read in a doctor’s office or a community setting, without specialised laboratory equipment. The sample taken is usually either finger-prick blood or saliva.
For people taking a test, the defining feature is that the result can usually be given within 20 or 30 minutes, which is often more convenient and can mean that many more people actually receive their test results.
According to MRAResearch’s new survey, global Rapid Tests market is projected to reach US$ 14630 million in 2033, increasing from US$ 10510 million in 2022, with the CAGR of 4.4% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Rapid Tests market research.
Factors such as increase in awareness regarding early diagnosis of disease, prevalence of infectious diseases, and the need for low-cost diagnostic testing coupled with diagnosis accuracy are expected to boost the growth of the rapid tests market during the forecast period. In addition, growth in personalized care and increase in promotional activities by manufacturers encourage the use of rapid tests, thereby propelling the growth of the market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Rapid Tests market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Akers Biosciences, Inc.
Abbott
Becton, Dickinson and Company
Bio-rad Laboratories, Inc.
Cepheid, Inc.
Hologic, Inc.
Meridian Bioscience, Inc.
OraSure Technologies, Inc.
Quidel Corporation
Roche Diagnostics
Segment by Type
Over-the-counter (OTC) Rapid Test Product
Professional Rapid Test Product
Infectious Disease
Cardiology
Oncology
Pregnancy and Fertility
Toxicology
Glucose Monitoring
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Rapid Tests report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
For people taking a test, the defining feature is that the result can usually be given within 20 or 30 minutes, which is often more convenient and can mean that many more people actually receive their test results.
According to MRAResearch’s new survey, global Rapid Tests market is projected to reach US$ 14630 million in 2033, increasing from US$ 10510 million in 2022, with the CAGR of 4.4% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Rapid Tests market research.
Factors such as increase in awareness regarding early diagnosis of disease, prevalence of infectious diseases, and the need for low-cost diagnostic testing coupled with diagnosis accuracy are expected to boost the growth of the rapid tests market during the forecast period. In addition, growth in personalized care and increase in promotional activities by manufacturers encourage the use of rapid tests, thereby propelling the growth of the market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Rapid Tests market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Akers Biosciences, Inc.
Abbott
Becton, Dickinson and Company
Bio-rad Laboratories, Inc.
Cepheid, Inc.
Hologic, Inc.
Meridian Bioscience, Inc.
OraSure Technologies, Inc.
Quidel Corporation
Roche Diagnostics
Segment by Type
Over-the-counter (OTC) Rapid Test Product
Professional Rapid Test Product
Segment by Application
Infectious Disease
Cardiology
Oncology
Pregnancy and Fertility
Toxicology
Glucose Monitoring
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Rapid Tests report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source